These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity. Buryova H, Chalupsky K, Zbodakova O, Kanchev I, Jirouskova M, Gregor M, Sedlacek R. BMC Gastroenterol; 2013 Oct 30; 13():155. PubMed ID: 24172289 [Abstract] [Full Text] [Related]
6. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice. Weerachayaphorn J, Luo Y, Mennone A, Soroka CJ, Harry K, Boyer JL. J Hepatol; 2014 Jan 30; 60(1):160-6. PubMed ID: 23978715 [Abstract] [Full Text] [Related]
8. Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats. Wang H, Dan Z, Jiang H. J Huazhong Univ Sci Technolog Med Sci; 2008 Oct 30; 28(5):553-7. PubMed ID: 18846337 [Abstract] [Full Text] [Related]
9. Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells. Alaca N, Özbeyli D, Uslu S, Şahin HH, Yiğittürk G, Kurtel H, Öktem G, Çağlayan Yeğen B. Turk J Gastroenterol; 2017 Nov 30; 28(6):476-484. PubMed ID: 29086715 [Abstract] [Full Text] [Related]
11. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. Yu DK, Zhang CX, Zhao SS, Zhang SH, Zhang H, Cai SY, Shao RG, He HW. Acta Pharmacol Sin; 2015 Apr 30; 36(4):473-82. PubMed ID: 25832428 [Abstract] [Full Text] [Related]
12. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat. Frezza EE, Gerunda GE, Plebani M, Galligioni A, Giacomini A, Neri D, Faccioli AM, Tiribelli C. Dig Dis Sci; 1993 Jul 30; 38(7):1291-6. PubMed ID: 8325189 [Abstract] [Full Text] [Related]
17. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model. Wang YY, Lin SY, Chen WY, Liao SL, Wu CC, Pan PH, Chou ST, Chen CJ. J Ethnopharmacol; 2017 May 23; 204():58-66. PubMed ID: 28416441 [Abstract] [Full Text] [Related]
18. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease. Munoz-Garrido P, Marin JJ, Perugorria MJ, Urribarri AD, Erice O, Sáez E, Úriz M, Sarvide S, Portu A, Concepcion AR, Romero MR, Monte MJ, Santos-Laso Á, Hijona E, Jimenez-Agüero R, Marzioni M, Beuers U, Masyuk TV, LaRusso NF, Prieto J, Bujanda L, Drenth JP, Banales JM. J Hepatol; 2015 Oct 23; 63(4):952-61. PubMed ID: 26044126 [Abstract] [Full Text] [Related]
19. Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats. Han JM, Kim HG, Choi MK, Lee JS, Lee JS, Wang JH, Park HJ, Son SW, Hwang SY, Son CG. Exp Toxicol Pathol; 2013 Sep 23; 65(6):837-44. PubMed ID: 23298556 [Abstract] [Full Text] [Related]